Discover B2B leads for Technology & Software industry
Identify and research relevant prospects for B2B lead generation on Technology & Software sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 57 in our database
Found 426 in our records
HQ: Cambridge, Cambridgeshire, United Kingdom
AstraZeneca
AstraZeneca is a pharmaceutical company that discoShow more...vers, develops, manufactures, and markets prescription medicines.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@astrazeneca.com (100.0%)
-
Marc Dunoyer
Chief Strategy Officer
m**********r@astrazeneca.com
-
Richard Gallo
Oncology Contract Strategy Manager
r***********o@astrazeneca.com
-
Nabil Dharsi
Medical Science Liaison, Hematology
n**********i@astrazeneca.com
-
Dan Wygal
Executive Director of Contract and Channel Strategy
d*******l@astrazeneca.com
-
Claudia Lamp
Contract Sr Patient Safety Scientist
c**********p@astrazeneca.com
-
Tom Keith-Roach
President, Astrazeneca UK
t*************h@astrazeneca.com
-
Mary Richardson
Global Publications Director, OBU
m*************n@astrazeneca.com
-
Matthew Roe
VP, Head of Early Clinical Development - Cardiovascular, Renal, and Metabolic
m*********e@astrazeneca.com
-
Jennifer Schmoll
Global Marketing Director-Diabetes
j**************l@astrazeneca.com
-
Lee Bennett
Associate Regulatory Project Director
l*********t@astrazeneca.com
-
Jasmine Jansens
Clinical Site Monitor
j*************s@astrazeneca.com
-
Stephanie Kenney
Global Head of Corporate Affairs, Cardiovascular Renal and Metabolism
s********************i@astrazeneca.com
-
Giovanni Melillo
Vice President - Immuno-oncology, Global Medical Affairs
g**************o@astrazeneca.com
-
Karina Estevez
Human Resources Global Graduate Associate
k************z@astrazeneca.com
-
Francesco Dazzi
Professor of Regenerative and Haematological Medicine - KHP Lead for Cellular Therapies
f*************i@astrazeneca.com
-
Graham Belfield
g*************d@astrazeneca.com
-
Tony Pusic
t********c@astrazeneca.com
-
Ronnie Stevens
r************s@astrazeneca.com
-
Miriam Wu
m*******u@astrazeneca.com
-
James Thomas Coates
Principal
j**********s@astrazeneca.com
-
Chandler Chen
Investment Director, Healthcare Fund
c***********n@astrazeneca.com
-
Jelena Saillard
j*************d@astrazeneca.com
-
Debasree Purkayastha
d******************a@astrazeneca.com
-
Shameen Afif-Rider
s****************r@astrazeneca.com
-
Wilbur Washington
Oncology Senior Sales Specialist - Hematology/Solid Tumor
w***************n@astrazeneca.com
-
General Inquiries
contact@astrazeneca.com
-
General Inquiries
help@astrazeneca.com
HQ: Foster City, California, United States
Gilead Sciences
Gilead Sciences is a biopharmaceutical company thaShow more...t discovers, develops, manufactures and commercializes therapies for critical diseases.
HQ: Foster City, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: Jun 22, 1987
Number of Exits: 16
Company Type: For Profit
Stock Symbol: BIT:GILD
Operating Status: Active
20 Emails
2 Phones
Main email format: sarah.smith@gilead.com (82.4%)
-
Ahmed Afifi
Vice President - Region Head Latin America
a*********i@gilead.com
-
Kelsey Reedy
Talent Advisor
k**********y@gilead.com
-
Anhquan Nguyen
Senior Research Associate
a*****n@gilead.com
-
Jack Wessel
Associate General Counsel, IP
j*********l@gilead.com
-
Patrick Loerch
Senior Vice President, Clinical Data Science
p*****h@gilead.com
-
Rashad Burgess
Regional Sales Director
r************s@gilead.com
-
Brian Peters
Senior Director, Procurement
f*****n@gilead.com
-
Don Dennis
Director
d********s@gilead.com
-
Elysia K
Sr. Clinical Trial Management Associate
e******k@gilead.com
-
Merdad Parsey
EVP & CMO Gilead Sciences
m*****y@gilead.com
-
Stacey Ma
Executive Vice President, Pharmaceutical Development and Manufacturing,
m**********h@gilead.com
-
Ketki Malgaonkar
Regulatory Affairs Manager
k**************r@gilead.com
-
Abhishek Bachchan
a***************n@gilead.com
-
Yin Jonkman
Compensation and Benefits Manager EMEA a.i
y*********n@gilead.com
-
Ethan Grant
e*********t@gilead.com
-
Karim Lee
k*******e@gilead.com
-
Angie Hertz
a*********z@gilead.com
-
Fatima Farid
f**********d@gilead.com
-
Nara Ramakrishnan
n***************n@gilead.com
-
Unclassified inbox
public_affairs@gilead.com
HQ: Northbrook, Illinois, United States
Horizon Pharma
Horizon Therapeutics focuses on the development ofShow more... prescription drugs for mild to moderate pain relief and arthritis.
HQ: Northbrook, Illinois, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active
14 Emails
1 Phones
Main email format: ssmith@horizontherapeutics.com (54.5%)
-
Shvetali Thatte
s*************e@horizontherapeutics.com.If
2**********0
-
Tina Ventura
t**********a@horizontherapeutics.com
-
Lou Scerbo
l*****o@horizontherapeutics.com
-
Maria Tello
m****o@horizontherapeutics.com
-
Randall Schenck
r*************k@horizontherapeutics.com
-
Paul Vanek
p********k@horizontherapeutics.com
-
Anne O'Donnell
a*******l@horizontherapeutics.com
-
Todd Smith
t****h@horizontherapeutics.com
-
James Inglis
j*****s@horizontherapeutics.com
-
John Croatt
Regional Account Director
j*********t@horizontherapeutics.com
-
Liz Gutierrez
l********z@horizontherapeutics.com
-
Susanna Frydryk
s******k@horizontherapeutics.com
-
Customer Service
customerservice@horizontherapeutics.com
-
Unclassified inbox
jwhalen@horizonpharma.com
HQ: Durham, North Carolina, United States
KBI Biopharma
KBI Biopharma, Inc. (KBI) is a leading developmentShow more... and contract manufacturing organization serving the biopharmaceutical industry. We help
HQ: Durham, North Carolina, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Apr 15, 2024
Founded Date: 1996
Number of Exits: 3
Company Type: For Profit
Operating Status: Active
13 Emails
0 Phones
Main email format: ssmith@kbibiopharma.com (100.0%)
-
Chad Cleveland
Director - Data Integrity | Global Quality & Compliance
c********d@kbibiopharma.com
-
Nicolas Fouque
Director of Manufacturing Science and Technologies - Geneva
n*****e@kbibiopharma.com
-
Allison Fallon
Talent Acquisition Specialist III
a*****n@kbibiopharma.com
-
Davinder Singh
Vice President Finance
d****h@kbibiopharma.com
-
Jeanie Lipscombe
Recruiting Specialist
j*****s@kbibiopharma.com
-
Robin Elleston
Director Of Quality Assurance
r*******n@kbibiopharma.com
-
Thomas Bellocci
Supply Chain Director
t*******i@kbibiopharma.com
-
Simon Bickley
Director Global Procurement
s******y@kbibiopharma.com
-
Chandra Kelley
Vice President, Business Development
c*****y@kbibiopharma.com
-
Chioma Otti
Microbiology Specialist
c***i@kbibiopharma.com
-
Marykay Marchigiani
Chief Financial Officer
m**********i@kbibiopharma.com
-
Unclassified inbox
swakefield@kbibiopharma.com
-
General Inquiries
contact@kbibiopharma.com
HQ: Tarrytown, New York, United States
Regeneron
Regeneron Pharmaceuticals specializes in the discoShow more...very, development, and commercialization of innovative medicines.
HQ: Tarrytown, New York, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Sep 6, 2024
Venture Stage: Early Stage Venture
Founded Date: 1988
Number of Exits: obfuscatedobfuscated
Company Type: For Profit
Stock Symbol: NASDAQ:REGN
Operating Status: Active
11 Emails
0 Phones
Main email format: sarah.smith@regeneron.com (100.0%)
-
Boris Gorovits
b************s@regeneron.com
-
Jacky Space
j**************e@regeneron.com
-
Petra Rietschel
Senior Director Clinical Development ImmunoOncology
p*************l@regeneron.com
-
Catherine Armstrong Bccl
c************l@regeneron.com
-
Mena Soliman
m**********n@regeneron.com
-
Heather Hammond
h*************d@regeneron.com
-
Sarah Ghosh
s*********h@regeneron.com
-
Sofia Caruso
s**********o@regeneron.com
-
Jimmy Sanders
j***********s@regeneron.com
-
Lisa Flanagan
Director, Patent Attorney- Therapeutics IP
l***********n@regeneron.com
-
Madison Lee
madison.lee@regeneron.com
-
General Inquiries
info@regeneron.com
HQ: San Diego, California, United States
Sorrento Therapeutics
Sorrento Therapeutics is focused on the developmenShow more...t of proprietary drug therapeutics for addressing unmet medical needs.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2024
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SRNE
Operating Status: Active
14 Emails
0 Phones
Main email format: ssmith@sorrentotherapeutics.com (100.0%)
-
Jaisim Shah
President & Chief Executive Officer
j***h@sorrentotherapeutics.com
-
Yan Li
Senior Scientist, Antibody Technology Development
y*i@sorrentotherapeutics.com
-
Dean Ferrigno
Vice President Of Finance
d*******o@sorrentotherapeutics.com
-
Vanessa Mendez
Quality
v*****z@sorrentotherapeutics.com
-
Ryan Tang
It Director
r***g@sorrentotherapeutics.com
-
Dindo Sy Chu
Vice President Finance
d**u@sorrentotherapeutics.com
-
Hua Huang
Director
h****g@sorrentotherapeutics.com
-
Mark Brunswick
SVP Head of Regulatory Affairs and Quality
m********k@sorrentotherapeutics.com
-
Silvia Chang
Head of Small Molecule Program Management/Executive Director Program Management
s****g@sorrentotherapeutics.com
-
Meredith Childers
Senior Writer
m*******s@sorrentotherapeutics.com
-
General Inquiries
info@sorrentotherapeutics.com
-
Admin Team
admin@sorrentotherapeutics.com
-
Management Department
manager@sorrentotherapeutics.com
-
Legal Department
legal@sorrentotherapeutics.com
HQ: Boston, Massachusetts, United States
Ginkgo Bioworks
Ginkgo Bioworks is a developer of biological enginShow more...eering products and custom microbes across multiple markets.
HQ: Boston, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial
Business Type: Public
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 27, 2024
Founded Date: 2008
Number of Exits: 1
Company Type: For Profit
Stock Symbol: BMV:DNA
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah@ginkgobioworks.com (62.5%)
-
Christina Agapakis
Creative Director
c*******a@ginkgobioworks.com
-
Ken Situ
It Consultant
k******u@ginkgobioworks.com
-
Zachary King
Director Of Marketing Operations
z**********g@ginkgobioworks.com
-
Jhonny Martinez
Facilities Technician
j*************z@ginkgobioworks.com
-
Sean Leblanc
Senior Director of Foundry Operations
s**n@ginkgobioworks.com
-
Yaoyu Yang
Principal Software Engineer
y***u@ginkgobioworks.com
-
Tomek Brzezinski
Automation Engineer
t***k@ginkgobioworks.com
-
Soon Gang Choi
Senior Test Engineer
s**n@ginkgobioworks.com
-
Ian Meyer
Associate Director, Strategic Finance
i*n@ginkgobioworks.com
-
General Inquiries
info@ginkgobioworks.com
HQ: New York, New York, United States
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
11 Emails
0 Phones
Main email format: ssmith@loxooncology.com (87.5%)
-
Lee S Scheible
Director, Early Phase Oncology, Loxo Oncology at Lilly
l*******e@loxooncology.com
-
Jinmi Heo
Director
j**o@loxooncology.com
-
Tamas Benkovics
Director
t********s@loxooncology.com
-
Alba Luengo
Principal Scientist
a*****o@loxooncology.com
-
Bojana Jovanovic
Senior Scientific Lead, Clinical Biomarker Development
b********c@loxooncology.com
-
Tracey Marrone
Talent Acquisition Manager
t******e@loxooncology.com
-
Nathan Wright
Research Fellow
n*****t@loxooncology.com
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com
HQ: San Diego, California, United States
Mirati Therapeutics
Mirati Therapeutics is a Biotechnology company locShow more...ated in 9363 Towne Centre Dr, San Diego, CA, United States.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Jan 24, 2024
Founded Date: Dec 13, 1995
Company Type: For Profit
Stock Symbol: NASDAQ:MRTX
Operating Status: Active
8 Emails
0 Phones
Main email format: ssmith@mirati.com (60.0%)
-
James Christensen
Chief Scientific Officer
c**********j@mirati.com
-
Jing He
Associate Director Biostatistics
j*e@mirati.com
-
Maggie Ryan Laughlin
Human Resources Director, Human Resources Business Partner
l*******m@mirati.com
-
Roch Switlik
Head Of Supply Chain Management
r**h@mirati.com
-
Stephen K Lee
Associate Director
l**s@mirati.com
-
Augustine Bourne
a*****e@mirati.com
-
Lisa Trapp
Senior Director, Finance
l****p@mirati.com
-
General Inquiries
info@mirati.com
HQ: Cambridge, Massachusetts, United States
Genzyme
Genzyme Corporation (Genzyme) is a biotechnology cShow more...ompany. The Company's product and service portfolio is focused on rare genetic disease
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Private
Employees: 10001+
Last Investment Activity: Jul 30, 2024
Founded Date: 1981
Number of Exits: 3
Company Type: For Profit
Operating Status: Closed
7 Emails
0 Phones
Main email format: sarah.smith@genzyme.com (100.0%)
-
Helene Nagy
Label Development Manager, Clinical Supplies
h*********y@genzyme.com
-
Patti Nardi
Head of Global Product Supply Chain
p*********i@genzyme.com
-
Philippe Mazars
Quality Control Associate Director
p*************s@genzyme.com
-
Bryan Gillis
b**********s@genzyme.com
-
Eliana Clark
Chief Technical Officer
e**********k@genzyme.com
-
Morrill Reynolds
Principal Project Manager
m**************s@genzyme.com
-
Louise Harney
louise.harney@genzyme.com
-
General Inquiries
info@genzyme.com
HQ: Cambridge, Cambridgeshire, United Kingdom
Horizon Discovery
Horizon is a gene editing company that designs & eShow more...ngineers genetically-modified cells, applying them to advance human health.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Health Diagnostics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 10, 2022
Founded Date: Jun 2007
Company Type: For Profit
Stock Symbol: LSE:HZD
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@horizondiscovery.com (100.0%)
-
Kevin Koker
Customer Service Manager
k*********r@horizondiscovery.com
-
Jon Aviles
General Manager
j********s@horizondiscovery.com
-
Natalie Cowan
Business Development Manager
n***********n@horizondiscovery.com
-
Jon Nunez
Vice President , Finance
j*******z@horizondiscovery.com
-
Jeffrey Dale
Business Development Manager, Midwest (South), Products and Services (including In Vivo)
j**********e@horizondiscovery.com
-
Abhay Joshi
Business Development Manager
a*********i@horizondiscovery.com
-
Hadas Raveh-Amit
Senior Scientist
h*************t@horizondiscovery.com
-
General Inquiries
info@horizondiscovery.com
-
Sales Department
sales@horizondiscovery.com
-
Legal Department
legal@horizondiscovery.com
HQ: Cambridge, Massachusetts, United States
Cullinan Oncology
Cullinan Oncology is a developer of an externally Show more...sourced cancer therapeutics used to end a drug program quickly.
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 2017
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEM
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@cullinanoncology.com (100.0%)
-
Corinne Savill
Chief Business Officer
c*****l@cullinanoncology.com
-
Nadim Ahmed
President and CEO
n****d@cullinanoncology.com
-
Jennifer Michaelson
Chief Development Officer
j*********n@cullinanoncology.com
-
Leslie Mariani
Vice President, Finance and Operations
l******i@cullinanoncology.com
-
Jeffrey Trigilio
Chief Financial Officer
j*******o@cullinanoncology.com
-
Sal Firicano
VP and Head of Information Technology
s*******o@cullinanoncology.com
-
General Inquiries
info@cullinoncology.com
HQ: South San Francisco, California, United States
Cytokinetics
Cytokinetics is a biopharmaceutical company develoShow more...ping therapies for debilitating diseases.
HQ: South San Francisco, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Mar 15, 2024
Founded Date: 1998
Company Type: For Profit
Stock Symbol: NASDAQ:CYTK
Operating Status: Active
9 Emails
0 Phones
Main email format: ssmith@cytokinetics.com (100.0%)
-
Robert Blum
President & CEO
r***m@cytokinetics.com
-
Kymberly Hernandez
HR Director, Commercial and Medical Affairs
k********z@cytokinetics.com
-
Dean Reid
d***d@cytokinetics.com
-
Regina Sohn
Medical Director
r***n@cytokinetics.com
-
Tina Controy
t******y@cytokinetics.com
-
General Inquiries
info@cytokinetics.com
-
Investor Relations
investor@cytokinetics.com
-
Legal Department
legal@cytokinetics.com
-
Unclassified inbox
medicalaffairs@cytokinetics.com
HQ: Paris, Ile-de-France, France
InVivo
InVivo helps agriculture cooperation regain their Show more...rightful place in the global food value chain.
HQ: Paris, Ile-de-France, France
Specialized In: AgTech, Pharmaceuticals, Healthcare & Medical
Business Type: Private
Employees: 5001-10000
Rounds: Private Equity
Last Investment Activity: Mar 5, 2024
Founded Date: 1945
Company Type: For Profit
Operating Status: Active
10 Emails
0 Phones
Main email format: ssmith@invivo-group.com (100.0%)
-
Maha Fournier
Group Chief Financial and Operating Officer
m*******r@invivo-group.com
-
Nathalie BAROTTE
Gestionnaire de carrières & RRH International
n******e@invivo-group.com
-
Edouard Lanckriet
e********t@invivo-group.com
-
Romain Affanni
r******i@invivo-group.com
-
Delphine CAMUS
d****s@invivo-group.com
-
General Inquiries
info@invivo-group.com
-
Admin Team
admin@invivo-group.com
-
Customer Service
support@invivo-group.com
-
General Inquiries
contact@invivo-group.com
-
Sales Department
sales@invivo-group.com
HQ: New York, New York, United States
Owkin
Owkin is an AI precision medicine company with a vShow more...ision to find the right drug for every patient.
HQ: New York, New York, United States
Specialized In: AI & Machine Learning, Pharmaceuticals, Healthcare SaaS, SaaS
Business Type: Private
Employees: 251-500
Rounds: Series B
Last Investment Activity: Mar 26, 2024
Founded Date: 2016
Company Type: For Profit
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@owkin.com (50.0%)
-
Thomas Clozel
Co-Founder & CEO
tc@owkin.com
-
Thomas Clozel
Co-Founder & CEO
t***********l@owkin.com
-
Gilles Wainrib
Founder
gw@owkin.com
-
Darius Meadon
Chief Marketing Officer
d***********n@owkin.com
-
Antonia Twiston-Davies
a************r@owkin.com
-
General Inquiries
hello@owkin.com
-
Customer Service
support@owkin.com
-
General Inquiries
contact@owkin.com
-
Sales Department
sales@owkin.com
-
Legal Department
legal@owkin.com
HQ: South San Francisco, California, United States
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical companShow more...y with one approved product.
HQ: South San Francisco, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Jan 16, 2024
Founded Date: 1996
Company Type: For Profit
Stock Symbol: NASDAQ:TBPH
Operating Status: Active
8 Emails
0 Phones
Main email format: ssmith@theravance.com (100.0%)
-
Christopher Porter
Vice President, Development Strategy and Innovation
c*****r@theravance.com
-
Kerry Zampa
Head, Global Learning & Organization Development
k****a@theravance.com
-
Venkat Vutukuri
BI Analytics Lead Architect
v*******i@theravance.com
-
Punam Shaida
p*****a@theravance.com
-
Jesse Fecker
Senior Director, Chief US Patent Counsel
j*****r@theravance.com
-
General Inquiries
medinfo@theravance.com
-
General Press Inquiries
cypress@theravance.com
-
Investor Relations
investor.relations@theravance.com
HQ: Carlsbad, California, United States
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotShow more...echnology company developing novel cellular therapies to treat unmet medical needs.
HQ: Carlsbad, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Coaching & Consulting, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 6, 2024
Founded Date: Jan 1, 1990
Number of Exits: 1
Company Type: For Profit
Stock Symbol: TLV:BTX
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@lineagecell.com (100.0%)
-
Jill Howe
Chief Financial Officer
j***e@lineagecell.com
-
Brian Culley
Chief Executive Officer at BioTime, Inc. (NYSE:BTX)
b*****y@lineagecell.com
-
Dan Giles
Business Development Manager
d****s@lineagecell.com
-
Aleksandra Jovanovic Poole
Vice President, Product Development
a****e@lineagecell.com
-
General Inquiries
info@lineagecell.com
-
General Inquiries
contact@lineagecell.com
-
Legal Department
legal@lineagecell.com
HQ: Suzhou, Jiangsu, China
Ascentage Pharma
Ascentage is a clinical-stage biopharmaceutical coShow more...mpany that develops drugs for the treatment of cancer.
HQ: Suzhou, Jiangsu, China
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Private
Employees: 101-250
Rounds: Series C
Last Investment Activity: Jan 2, 2024
Founded Date: 2009
Company Type: For Profit
Operating Status: Active
7 Emails
0 Phones
Main email format: ssmith@ascentagepharma.com (66.7%)
-
Muyun Yang
Investor Relations Manager
s***g@ascentagepharma.com
-
George Wong
Vice President of Product Development and Production
g***g@ascentagepharma.com
-
Geetha Bhat
Clinical Study manager, Clinical Operations
g*********t@ascentagepharma.com
-
Sherry Sun
Senior Medical Director
s**n@ascentagepharma.com
-
Unclassified inbox
PR@ascentagepharma.com
-
Unclassified inbox
bd@ascentagepharma.com
-
Unclassified inbox
cyang@ascentagepharma.com
HQ: Dublin, Dublin, Ireland
Shire
Shire biotechnology company that focuses on servinShow more...g people with rare diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics, Wellness
Acquired by: Takeda
Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: May 14, 2024
Founded Date: 1986
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:SHPG
Operating Status: Closed
9 Emails
0 Phones
Main email format: ssmith@shire.com (100.0%)
-
Katelyn Mallozzi
Head of Global Planning and Design
k*******i@shire.com
-
Scott Donald
UK Head of Neuroscience
s*****d@shire.com
-
Nirvan Hulangamuwa
Finance Business Partner
n**********a@shire.com
-
Victor Otcheretko
v*********o@shire.com
-
General Inquiries
info@shirehousing.com
-
General Inquiries
info@shirefoods.com
-
Unclassified inbox
golf@theshirelondon.com
-
Unclassified inbox
shire@woodanilling.wa.gov.au
-
Unclassified inbox
abcdefghij@shire.com
HQ: Seattle, Washington, United States
CTI BioPharma
CTI BioPharma is a biopharmaceutical company develShow more...oping oncology products for the treatment of blood-related cancers.
HQ: Seattle, Washington, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Debt
Last Investment Activity: Jun 26, 2023
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:CTIC
Operating Status: Active
4 Emails
0 Phones
Main email format: ssmith@ctibiopharma.com (100.0%)
-
Chuck Bianco
c*****o@ctibiopharma.com
-
Natalie Jaynes Brunner
Key Account Manager
n******r@ctibiopharma.com
-
patrizia angiuli
p******i@ctibiopharma.com
-
General Inquiries
medinfo@ctibiopharma.com
HQ: Mechelen-bovelingen, Limburg, Belgium
Galapagos
Galapagos is a clinical-stage biotechnology companShow more...y, specialized in the discovery and development of small molecule medicines with novel.
HQ: Mechelen-bovelingen, Limburg, Belgium
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Feb 25, 2024
Founded Date: 1999
Company Type: For Profit
Stock Symbol: VIE:GLPG
Operating Status: Active
7 Emails
0 Phones
Main email format: sarah.smith@glpg.com (100.0%)
-
Werner Cautreels
Director
w**************s@glpg.com
-
Francois Normant
Director Human Resources France
f**************t@glpg.com
-
Raphaëlle LACHAT
r**************t@glpg.com
-
General Inquiries
info@glpg.com
-
Customer Service
support@glpg.com
-
Legal Department
legal@glpg.com
-
Unclassified inbox
dpo@glpg.com
HQ: New York, New York, United States
Roivant Sciences
Roivant Sciences is a biopharmaceutical company foShow more...cused on the development of medicines and healthcare technologies to patients.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 25, 2024
Founded Date: May 2014
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ROIV
Operating Status: Active
4 Emails
0 Phones
Main email format: sarah.smith@roivant.com (100.0%)
-
Matthew Gline
Chief Financial Officer
m***********e@roivant.com
-
Tanya Shaby
Partner, Legal
t*********y@roivant.com
-
Jamie Schiff
Software Engineer
j**********f@roivant.com
-
General Inquiries
info@roivant.com
HQ: Uniondale, New York, United States
Angion
Angion Biomedica is a clinical stage organ restoraShow more...tion biopharmaceutical company focused on renal disease.
HQ: Uniondale, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2023
Founded Date: 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:ANGN
Operating Status: Closed
4 Emails
1 Phones
Main email format: sarah@angion.com (50.0%)
-
Jay Venkatesan
President, Chief Executive Officer and Director
j*********n@angion.com
-
Jay Venkatesan
President, Chief Executive Officer and Director
j*y@angion.com
*************1
-
Itzhak Goldberg
Director & Chairman Emeritus
-
Legal Department
legal@angion.com
-
Unclassified inbox
mail@angion.com
HQ: London, England, United Kingdom
Deep Science Ventures
DSV is a venture studio and a fund that develops aShow more... systematic, optimized approach to science company development and investment.
HQ: London, England, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial, Venture Capital
Business Type: Private
Employees: 11-50
Rounds: Seed
Last Investment Activity: Feb 29, 2024
Founded Date: 2016
Company Type: For Profit
Operating Status: Active
Investor Type: Accelerator, Incubator, Venture Capital
3 Emails
0 Phones
Main email format: sarah@deepscienceventures.com (100.0%)
-
Dominic Falcao
Founding Director
d*m@deepscienceventures.com
-
Brock Doiron
Senior Associate, Computation
b***k@deepscienceventures.com
-
Laura Fletcher
Head of Business Development and Strategic Partnerships in Theraputics
-
Eirini Malliaraki
Head of Founder Community
-
Thane Campbell
VENTURE SCIENCE DOCTORATE PROJECT LEAD
-
Alexandra Sakatos
Venture Founder
-
Bill Yost
Venture Partner
-
Samuel Sowah Mensah
Scale Project Lead
-
Mark Hammond
Founding Director
-
General Inquiries
hello@deepscienceventures.com
HQ: Monmouth Junction, New Jersey, United States
Angel Medical Systems
Angel Medical Systems is a medical company that ofShow more...fers AngelMed Guardian an implantable cardiac monitoring and alerting system.
HQ: Monmouth Junction, New Jersey, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Private
Employees: 11-50
Rounds: Venture - Series Unknown
Last Investment Activity: Mar 1, 2023
Founded Date: 2001
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
5 Emails
0 Phones
Main email format: ssmith@angel-med.com (100.0%)
-
Gordie Nye
Chief Executive Officer
g**e@angel-med.com
-
Robert Fischell
Founder & Chairman
-
General Inquiries
info@angel-med.com
-
Customer Service
support@angel-med.com
-
Sales Department
sales@angel-med.com
-
Legal Department
legal@angel-med.com
HQ: Bangalore, Karnataka, India
Biocon
Biocon is a healthcare and technology, company focShow more...used on biotechnology.
HQ: Bangalore, Karnataka, India
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 26, 2024
Founded Date: 1978
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NSE:BIOCON
Operating Status: Active
2 Emails
0 Phones
Main email format: sarah.smith@biocon.com (100.0%)
-
Biswajit Samanta
Associate Scientific Manager II-Primary Packaging and Medical Device Development
b**************a@biocon.com
-
Daniel M. Bradbury
Director
-
Murali Krishna
Founder
-
Jack Wong
Head of Regulatory Affairs, MOW
-
Kiran Mazumdar-Shaw
Founder, Chairperson and Managing Director
-
Unclassified inbox
contact.us@biocon.com
HQ: Wadenswil, Zurich, Switzerland
Numab
Numab is a biotechnology company that offers antibShow more...ody-based therapeutics for the treatment of severe diseases.
HQ: Wadenswil, Zurich, Switzerland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Series C
Last Investment Activity: Feb 13, 2024
Founded Date: 2011
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
4 Emails
1 Phones
Main email format: s.smith@numab.com (100.0%)
-
David Urech
CSO, and Co-CEO, Founder
d*****h@numab.com
T***********************************************************************************m
-
Oliver Middendorp
CBO, Co-CEO, and Co-Founder
-
Peter Lichtlen
CMO and Co-Founder
-
Tea Gunde
Head of Pharmacology
-
Sebastian Meyer
Chief Operating Officer
-
Roland Helfenstein
Chief Financial Officer
-
General Inquiries
info@numab.com
-
Admin Team
admin@numab.com
-
Legal Department
legal@numab.com
HQ: Cambridge, Cambridgeshire, United Kingdom
Acacia Pharma
Acacia Pharma is a pharmaceutical company engaged Show more...in the R&D of supportive care drugs for cancer patients.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 51-100
Rounds: Debt Financing
Last Investment Activity: May 20, 2022
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Stock Symbol: EPA:ACPH
Operating Status: Active
2 Emails
0 Phones
Main email format: sarahsmith@acaciapharma.com (100.0%)
-
Ravindra Joshi
Vice President , Finance
r***********i@acaciapharma.com
-
Robert Gristwood
CSO
-
General Inquiries
info@acaciapharma.com
HQ: Jupiter, Florida, United States
Dyadic International
Dyadic International is a biotechnology company, dShow more...eveloping and manufacturing bio-based chemicals.
HQ: Jupiter, Florida, United States
Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial
Business Type: Public
Employees: 51-100
Rounds: Post-IPO Debt
Last Investment Activity: Jun 28, 2024
Founded Date: 1979
Company Type: For Profit
Stock Symbol: NASDAQ:DYAI
Operating Status: Active
7 Emails
1 Phones
Main email format: ssmith@dyadic.com (100.0%)
-
Joe Hazelton
Chief Business Office
j*******n@dyadic.com
***********4
-
Thomas Dubinski
Vice President and Chief Financial Officer
-
Doug Pace
Executive Vice President of Business Development
-
Robert D. Burke
MD
-
Mark A. Emalfarb
Founder, Chairman & CEO
-
Ronen Tchelet
Chief Scientific Officer
-
Investor Relations
IR@dyadic.com
-
General Inquiries
info@dyadic-agency.com
-
Unclassified inbox
information@dyadic.com
-
Unclassified inbox
prawson@dyadic.com
-
Investor Relations
ir@dyadic.com
-
General Inquiries
-info@dyadic.com
HQ: Armadale, Victoria, Australia
Immuron
Immuron focuses on oral immunotherapy using polyclShow more...onal antibody products for humans.
HQ: Armadale, Victoria, Australia
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 1-10
Rounds: Grant
Last Investment Activity: Jul 15, 2024
Founded Date: 1994
Company Type: For Profit
Stock Symbol: NASDAQ:IMRN
Operating Status: Active
4 Emails
0 Phones
Main email format: sarah@immuron.com (100.0%)
-
Steven Lydeamore
CEO
s****n@immuron.com
-
Phillip Hains
Company Secretary & CFO
-
Jerry Kanellos
CEO
-
General Inquiries
info@immuron.com
-
General Inquiries
hello@immuron.com
-
Sales Department
sales@immuron.com
HQ: New York, New York, United States
Q BioMed
A biomedical acceleration and development company .
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 1-10
Rounds: Post-IPO Equity
Last Investment Activity: Jun 23, 2023
Founded Date: 2013
Company Type: For Profit
Stock Symbol: OTCQB:QBIO
Operating Status: Active
2 Emails
0 Phones
-
Denis D Corin
CEO and Chairman
d****n@qbiomed.com
-
Enrique Navas
Founder
-
General Inquiries
info@qbiomed.com
HQ: San Diego, California, United States
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a neuro-biotechnology coShow more...mpany developing treatments for neuro-based disorders.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Aug 4, 2023
Founded Date: 2006
Company Type: For Profit
Stock Symbol: NASDAQ:ADMP
Operating Status: Active
1 Emails
0 Phones
-
Dennis J. Carlo
Founder & CEO
-
David C. Benedicto
Chief Financial Officer
-
General Inquiries
info@adamispharma.com
HQ: Redwood City, California, United States
PMV Pharmaceuticals
PMV Pharmaceuticals is a developer of p53-targetedShow more... small molecule drugs for the treatment of cancer.
HQ: Redwood City, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 51-100
Rounds: Series D
Last Investment Activity: Mar 27, 2024
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:PMVP
Operating Status: Active
1 Emails
0 Phones
-
Arnold Levine
Co-Founder
-
Leila Alland
Chief Medical Officer
-
David Mack
Co-Founder, President & CEO
-
Tim Smith
SVP, Head of Corporate Development
-
Thomas Shenk
Co-Founder & Member, Scientific Advisory Board
-
Michael Carulli
Chief Financial Officer
-
General Inquiries
info@pmvpharma.com
HQ: Gaithersburg, Maryland, United States
Sirnaomics
Sirnaomics is a biopharmaceutical company developiShow more...ng therapeutics for critical human diseases by using RNA interference technology.
HQ: Gaithersburg, Maryland, United States
Specialized In: Pharmaceuticals, Biotechnology, Medical Devices
Business Type: Private
Employees: 101-250
Rounds: Grant
Last Investment Activity: Dec 1, 2023
Founded Date: 2007
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Patrick Y. Lu
Founder, President and CEO
-
David Evans
Chief Scientific Officer and Co-Founder
-
Nigel Yip
Vice President, Corporate Finance
-
George Ji
Chief Operation Officer and Co-Founder
-
Allan Shaw
Chief Financial Officer
-
John Buergenthal
Vice President, Human Resources
-
Dmitry Samarsky
Chief Technology Officer
-
Francois Lebel
Senior Vice President for Preclinical and Clinical Development
-
Unclassified inbox
info-office@sirnaomics.com
HQ: Mainz, Rheinland-Pfalz, Germany
BioNTech
BioNTech is a biopharmaceutical company pioneeringShow more... the development of individualized therapies for cancer and other diseases.
HQ: Mainz, Rheinland-Pfalz, Germany
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 2008
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:BNTX
Operating Status: Active
1 Emails
0 Phones
-
Ugur Sahin
Co-Founder and CEO
-
Christoph Huber
Cofounder & deputy chair supervisory board
-
Christoph Kröner
Director DNA Process Development & Cap Technology
-
Özlem Türeci
Founder & CMO
-
Jesse Dong
Vice President, Peptide Chemistry
-
Andreas Kuhn
Senior Vice President RNA Biochemistry & Manufacturing
-
Annemarie Hanekamp
Chief Commercial Officer
-
Michael Boehler
Vice President Global Commercial and General Manager
-
General Inquiries
info@biontech.de
HQ: Tokyo, Tokyo, Japan
Sosei Group
Sosei is a Japanese biopharmaceutical company thatShow more... develops and commercializes innovative drugs.
HQ: Tokyo, Tokyo, Japan
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 11-50
Rounds: Grant
Last Investment Activity: Feb 15, 2024
Founded Date: Jun 1990
Number of Exits: 1
Company Type: For Profit
Stock Symbol: TYO:4565
Operating Status: Active
1 Emails
0 Phones
-
Toshihiro Maeda
Chief Operating Officer
-
Shinichi Tamura
Founder, Representative Executive Officer & Chief Executive
-
Hidetoshi Torami
Executive Vice President & CFO
-
Malcolm Weir
Executive Vice President, Chief R&D Officer
-
Fiona Marshall
Executive Vice President and Chief Scientific Officer
-
Unclassified inbox
wben34690@gmail.com
HQ: Hebei, Hebei, China
Meihua Group
Meihua Group is a large-scale joint venture integrShow more...ating research, development and production
HQ: Hebei, Hebei, China
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 10001+
Rounds: Series A
Last Investment Activity: May 16, 2017
Founded Date: 2002
Company Type: For Profit
Stock Symbol: SSE:600873
Operating Status: Active
HQ: Hefei, Anhui, China
HTBT
HTBT is a biopharmaceutical manufacturer that focuShow more...ses on international biotechnology introduction and absorption.
HQ: Hefei, Anhui, China
Specialized In: Pharmaceuticals, Biotechnology, Technology & Software, Manufacturing & Industrial, Healthcare & Medical
Business Type: Private
Employees: 101-250
Rounds: Series E
Last Investment Activity: Dec 21, 2016
Founded Date: Oct 26, 2007
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Xiaoming Gao
Founder & Chairman
-
Unclassified inbox
tianmai@htbt.com.cn
HQ: Houston, Texas, United States
ImmunoMet Therapeutics
ImmunoMet Therapeutics is a biopharmaceutical compShow more...any that develops and commercializes oncology products for cancer patients.
HQ: Houston, Texas, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Series B
Last Investment Activity: Jul 26, 2021
Founded Date: 2015
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
Edward Garmey
Consultant CMO
-
Sungwuk Kim
CEO
-
Revati Shreeniwas
Chief Medical Officer
-
General Inquiries
info@immunomet.com
HQ: Kowloon City, Kowloon, Hong Kong
Jacobson Pharma
Hong Kong's largest generic drug maker
HQ: Kowloon City, Kowloon, Hong Kong
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Nov 25, 2022
Founded Date: 1998
Company Type: For Profit
Stock Symbol: HKG:2633
Operating Status: Active
1 Emails
0 Phones
-
Derek Sum
Founder, Chairman & Chief Executive Officer
-
Celine Heung Kwan Cheng
Executive Vice President
-
Kwong Yip Sum
CEO
-
Chun Bun Lo
Executive Director
-
Wai Ming Wong
CFO
-
Yu Sun Wong
Executive Vice President
-
Unclassified inbox
Jacobsonpharma@sprg.com.hk
HQ: Cambridge, Cambridgeshire, United Kingdom
Phico Therapeutics
Phico Therapeutics is a developer of novel platforShow more...m technology designed to overcome antibacterial resistance.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 1-10
Rounds: Venture - Series Unknown
Last Investment Activity: Feb 1, 2022
Founded Date: 2000
Company Type: For Profit
Operating Status: Active
3 Emails
0 Phones
-
Heather Fairhead
Founder & CEO
-
Katy Pitts
Facility manager and senior R&D scientist
-
James Cass
Manager of research and development
-
Anthony Martin
Chairman & Non Executive Director
-
General Inquiries
info@phicotx.co.uk
-
Admin Team
admin@phicotx.co.uk
-
General Inquiries
info@phicotherapeutics.co.uk
HQ: Vancouver, British Columbia, Canada
Novelion Therapeutics
Novelion Therapeutics Inc, formerly QLT Inc., is aShow more... Canada-based biopharmaceutical company
HQ: Vancouver, British Columbia, Canada
Specialized In: Pharmaceuticals, Biotechnology, Hospitals & Clinics
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Aug 25, 2021
Founded Date: 1981
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NVLN
Operating Status: Active
1 Emails
0 Phones
-
Robert L. Butchofsky
President & CEO
-
Cameron R. Nelson
CFO
-
Investor Relations
ir@qltinc.com
HQ: Sioux Falls, South Dakota, United States
Raison
Raison fosters the advancement of biological ecosystems.
HQ: Sioux Falls, South Dakota, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Private
Rounds: Venture - Series Unknown
Last Investment Activity: Dec 19, 2023
Founded Date: Jan 1, 2018
Company Type: For Profit
Operating Status: Active
HQ: Incheon, Inch'on-jikhalsi, South Korea
SCM Lifescience
SCM Lifescience is a biotechnology company establiShow more...shed with the vision of developing treatment options for difficult to treat diseases
HQ: Incheon, Inch'on-jikhalsi, South Korea
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Private
Employees: 51-100
Rounds: Series C
Last Investment Activity: Jun 23, 2021
Founded Date: 2014
Company Type: For Profit
Operating Status: Active
Investor Type: Venture Capital
1 Emails
0 Phones
-
Sun U. Song
Founder, Chief Scientific Officer & Vice President
-
Investor Relations
scm-ir@scmlifescience.com
HQ: Tianjin, Guangdong, China
CanSinoBIO
Tianjin CanSino Biotechnology Inc. is a vaccine maShow more...nufacturing facility.
HQ: Tianjin, Guangdong, China
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 101-250
Rounds: Grant
Last Investment Activity: Mar 29, 2024
Founded Date: 2009
Company Type: For Profit
Stock Symbol: HKG:6185
Operating Status: Active
1 Emails
0 Phones
-
Dongxu Qiu
Senior VP, Business Development
-
Tao Zhu
Co-Founder, Executive Director and Chief Scientific Officer
-
Xuefeng Yu
Co-Founder, Chairma, and CEO
-
Shoubai Chao
Executive Director, Chief Operating Officer
-
General Inquiries
info@cansinotech.com
HQ: Woodridge, Illinois, United States
Advanced Life Sciences Holdings
Advanced Life Sciences Holdings, Inc. is a biopharShow more...maceutical company focused on the discovery, development and commercialization of drugs
HQ: Woodridge, Illinois, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Delisted
Employees: 1-10
Founded Date: 1998
Company Type: For Profit
Stock Symbol: NASDAQ:ADLS
Operating Status: Closed
HQ: Milano, Lombardia, Italy
BiovelocITA
BiovelocITA si dedica alla “accelerazione” di progShow more...etti in stadio precoce
HQ: Milano, Lombardia, Italy
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Private
Employees: 1-10
Rounds: Venture - Series Unknown
Last Investment Activity: Dec 13, 2023
Founded Date: 2015
Company Type: For Profit
Operating Status: Active
Investor Type: Accelerator
1 Emails
0 Phones
-
Gabriella Camboni
CEO
-
Silvano Spinelli
Chairman
-
General Inquiries
info@biovelocita.com
HQ: Redwood City, California, United States
PMV Pharmaceuticals
PMV Pharmaceuticals is a developer of p53-targetedShow more... small molecule drugs for the treatment of cancer.
HQ: Redwood City, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 51-100
Rounds: Series D
Last Investment Activity: Apr 11, 2024
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:PMVP
Operating Status: Active
HQ: Redwood City, California, United States
PMV Pharmaceuticals
PMV Pharmaceuticals is a developer of p53-targetedShow more... small molecule drugs for the treatment of cancer.
HQ: Redwood City, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 51-100
Rounds: Series D
Last Investment Activity: Mar 27, 2024
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:PMVP
Operating Status: Active
HQ: Ottawa, Ontario, Canada
Tetra Bio-Pharma
Tetra Bio-Pharma is a biopharmaceutical company thShow more...at focuses on cannabinoid-based drug development for inflammation, pain, and more.
HQ: Ottawa, Ontario, Canada
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Debt
Last Investment Activity: Aug 17, 2023
Founded Date: May 17, 2007
Number of Exits: 1
Company Type: For Profit
Stock Symbol: TSX:TBP
Operating Status: Active
1 Emails
0 Phones
-
Bernard Lessard
CFO
-
Guy Chamberland
CEO, CSO & Chief Regulatory Officer
-
Investor Relations
investors@tetrabiopharma.com
Heyuan Biotechnology
Heyuan Biotechnology is a national high-tech enterShow more...prise specializing in the R&D of plant-derived recombinant protein expression technology.
Specialized In: Pharmaceuticals, Biotechnology
Company Type: For Profit
Operating Status: Active
1 Emails
0 Phones
-
General Inquiries
info@undefined
HQ: Tokyo, Tokyo, Japan
AnGes
AnGes is a biopharmaceutical company with a missioShow more...n to provide patients, especially those suffering from disease.
HQ: Tokyo, Tokyo, Japan
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Seed
Last Investment Activity: Jan 18, 2024
Founded Date: Dec 17, 1999
Number of Exits: 1
Company Type: For Profit
Stock Symbol: TYO:4563
Operating Status: Active
1 Emails
0 Phones
-
EI Yamada
President & CEO
-
Andy G. Hinson
Senior Director of Clinical Development
-
General Inquiries
info@anges.co.jp
HQ: Hebei, Hebei, China
Meihua Group
Meihua Group is a large-scale joint venture integrShow more...ating research, development and production
HQ: Hebei, Hebei, China
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 10001+
Rounds: Series A
Last Investment Activity: Jun 18, 2022
Founded Date: 2002
Company Type: For Profit
Stock Symbol: SSE:600873
Operating Status: Active
HQ: San Diego, California, United States
Ambit Biosciences
Ambit Biosciences, a biopharmaceutical company, deShow more...velops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Acquired by: Daiichi Sankyo
Business Type: Delisted
Employees: 51-100
Rounds: Venture - Series Unknown
Last Investment Activity: Apr 17, 2019
Founded Date: 2000
Company Type: For Profit
Stock Symbol: NASDAQ:AMBI
Operating Status: Active
Regeneron
Regeneron Pharmaceuticals specializes in the discoShow more...very, development, and commercialization of innovative medicines.
Specialized In: Pharmaceuticals, Biotechnology
Founded Date: 1988
Number of Exits: obfuscatedobfuscated
Company Type: For Profit
Stock Symbol: NASDAQ:REGN
Operating Status: Active
1 Emails
0 Phones
-
General Inquiries
info@undefined
HQ: Suwanee, Georgia, United States
Beximco Pharmaceuticals
Beximco Pharmaceuticals operates in the PharmaceutShow more...ical Preparations.
HQ: Suwanee, Georgia, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Jan 30, 2024
Founded Date: 1976
Company Type: For Profit
Stock Symbol: LSE:BXP
Operating Status: Active
1 Emails
0 Phones
-
Nazmul Hassan
Chief Executive Officer and Director Marketing & Commercial.
-
Sohail F. Rahman
Chairman
-
General Inquiries
info@bpl.net
HQ: Barcelona, Catalonia, Spain
Grupo Ferrer Internacional
Grupo Ferrer Internacional is a manufactures, distShow more...ributes, and sells medicines, diagnostics, vaccines, fine chemicals and feed ingredients
HQ: Barcelona, Catalonia, Spain
Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial, Healthcare & Medical
Business Type: Private
Employees: 1001-5000
Rounds: Private Equity
Last Investment Activity: Mar 25, 2024
Founded Date: 1959
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
- «
- 1
- »
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.